Clin Obes. 2026 Aug;16(4):e70091. doi: 10.1111/cob.70091.ABSTRACTThe timing of obesity onset may influence long-term cardiovascular risk. Whether obesity beginning in early adulthood differs from obesity acquired later in life with respect to cardiometabolic and cardiovascular outcomes remains uncer
Circ Res. 2026 Jun 12. doi: 10.1161/CIRCRESAHA.125.326836. Online ahead of print.ABSTRACTBACKGROUND: In people living with HIV (PLWH), persistent systemic inflammation drives comorbidities, including cardiovascular and cerebrovascular diseases. Monocyte-mediated inflammation, rather than T-cell acti
Circ Res. 2026 Jun 12. doi: 10.1161/CIRCRESAHA.125.327472. Online ahead of print.ABSTRACTAtherosclerosis is a chronic disease of the arterial wall driven by complex interactions between vascular, immune, and stromal cells. For decades, our understanding of plaque biology relied on bulk assays that m
No abstractCirc Popul Health Outcomes. 2026 Jun 12:e013635. doi: 10.1161/CIRCOUTCOMES.126.013635. Online ahead of print.NO ABSTRACTPMID:42283076 | DOI:10.1161/CIRCOUTCOMES.126.013635
Circ Popul Health Outcomes. 2026 Jun 12:e012189. doi: 10.1161/CIRCOUTCOMES.125.012189. Online ahead of print.ABSTRACTBACKGROUND: Women, Black, and Hispanic patients bear a disproportionate burden of cardiovascular disease yet remain underrepresented in clinical trials. Understanding patient perspect
J Multidiscip Healthc. 2026 Jun 6;19:607851. doi: 10.2147/JMDH.S607851. eCollection 2026.ABSTRACTThe high mortality rate associated with coronary artery disease (CAD) represents a significant global health challenge. While home-based cardiac telerehabilitation (HBCTR) has emerged as a key area of re
Front Immunol. 2026 May 28;17:1831457. doi: 10.3389/fimmu.2026.1831457. eCollection 2026.ABSTRACTOxidized low-density lipoprotein (oxLDL) is a central driver of inflammatory responses in atherosclerosis and triggers multiple forms of regulated cell death beyond classical apoptosis. Ferroptosis, char
Regen Biomater. 2026 May 13;13:rbag096. doi: 10.1093/rb/rbag096. eCollection 2026.ABSTRACTOxygen is indispensable for sustaining tissue and cell physiological functions, yet a hypoxic microenvironment often arises in tissue injury and regeneration, impairing graft scaffold performance and hindering
bioRxiv [Preprint]. 2026 Jun 4:2026.06.01.729444. doi: 10.64898/2026.06.01.729444.ABSTRACTOBJECTIVE: Lipoprotein(a) [Lp(a)] is a causal cardiovascular disease (CVD) risk factor, with plasma concentrations generally higher in Black than White individuals. Evidence suggests that elevated Lp(a), partly
bioRxiv [Preprint]. 2026 Jun 2:2026.06.01.729434. doi: 10.64898/2026.06.01.729434.ABSTRACTPeriodontitis (PD) is a common chronic inflammatory condition and a risk factor for cardiovascular diseases (CVD), yet underlying linking mechanisms remain unclear. The cytokine Oncostain M (OSM) is elevated in
bioRxiv [Preprint]. 2026 Jun 3:2026.05.30.728950. doi: 10.64898/2026.05.30.728950.ABSTRACTBACKGROUND: Decreased hepatic removal of low density lipoproteins (LDL) and increased apolipoprotein B (apoB) production cause hypercholesterolemia, a major causal risk factor of atherosclerotic cardiovascular
Eur Heart J Imaging Methods Pract. 2026 May 16;4(1):qyag094. doi: 10.1093/ehjimp/qyag094. eCollection 2026 Jan.ABSTRACTAIMS: To scope the current European landscape of multi-modality cardiovascular imaging practices in immune-mediated inflammatory diseases (IMIDs).METHODS AND RESULTS: An electronic
Food Sci Nutr. 2026 Jun 9;14(6):e71995. doi: 10.1002/fsn3.71995. eCollection 2026 Jun.ABSTRACTType 2 diabetes mellitus (T2DM) is closely associated with central obesity, which further elevates cardiovascular disease risk. This randomized, open-label, parallel-controlled trial aimed to compare the ef
Bioinformation. 2026 Apr 30;22(4):2010-2014. doi: 10.6026/973206300222010. eCollection 2026.ABSTRACTTraditional cardiovascular risk models fail to detect subclinical atherosclerosis in a substantial proportion of asymptomatic individuals. Therefore, it is of interest to evaluate the prognostic value
Bioinformation. 2026 Apr 30;22(4):1924-1928. doi: 10.6026/973206300221924. eCollection 2026.ABSTRACTUncontrolled hypertension is one critical contributing factor to cardiovascular disease and continues to cause problems even through there are effective pharmacological and lifestyle interventions ava
Nano Res. 2021 Mar;14(3):762-769. doi: 10.1007/s12274-020-3111-3. Epub 2020 Nov 6.ABSTRACTAtherosclerotic cardiovascular disease is the leading cause of mortality in the world. A driving feature of atherosclerotic plaque formation is dysfunctional efferocytosis. Because the "don't eat me" molecule C
medRxiv [Preprint]. 2026 Jun 2:2026.05.26.26353962. doi: 10.64898/2026.05.26.26353962.ABSTRACTBACKGROUND: Androgen receptor pathway inhibitors (ARPIs) have transformed the treatment of high risk and metastatic prostate cancer, though are associated with increased cardiovascular risk. Glucagon-like p
medRxiv [Preprint]. 2026 Jun 3:2026.02.10.26345390. doi: 10.64898/2026.02.10.26345390.ABSTRACTMicro- and nanoplastics (MNPs) are increasingly detected in human tissues, yet their causal contribution to cardiovascular disease remains poorly understood. Here we show that oral exposure to polyethylene
medRxiv [Preprint]. 2026 Jun 3:2026.06.01.26354601. doi: 10.64898/2026.06.01.26354601.ABSTRACTINTRODUCTION: The Framingham Risk Score (FRS) indexes cardiovascular risk (CVR), but age-weighting may confound associations with brain and cognitive outcomes.METHODS: In 923 amyloid-positive ADNI participa
medRxiv [Preprint]. 2026 Jun 2:2026.05.26.26353833. doi: 10.64898/2026.05.26.26353833.ABSTRACTBACKGROUND: Individuals diagnosed with depression during pregnancy are more likely to develop cardiovascular disease (CVD) later in life. However, it remains unclear whether subclinical depressive symptoms
Bioimpacts. 2026 Apr 22;16:33050. doi: 10.34172/bi.33050. eCollection 2026.ABSTRACTModern healthcare demands warrant the reconceptualization of pharmaceutical practitioners as primary caregivers capable of addressing contemporary medical challenges. Their specialized knowledge in molecular therapeut
Rev Cuid. 2026 May 8;17(2):e4864. doi: 10.15649/cuidarte.4864. eCollection 2026 May-Aug.ABSTRACTINTRODUCTION: The 1-Minute Sit to Stand Test (STS1) has gained relevance as a simple, safe, and functional test in patients with cardiovascular disease, especially in settings where the 6-Minute Walk Test
Eur Heart J Open. 2026 May 22;6(3):oeag086. doi: 10.1093/ehjopen/oeag086. eCollection 2026 May.ABSTRACTAIMS: Stereotactic arrhythmia radiotherapy (STAR) is an emerging non-invasive option for refractory ventricular tachycardia (VT); yet, the underlying myocardial effects in humans remain poorly unde
Eur Heart J Open. 2026 Apr 30;6(3):oeag072. doi: 10.1093/ehjopen/oeag072. eCollection 2026 May.ABSTRACTAIMS: The 'FondAZione A. Gemelli IRCCS Artificial Intelligence Empowered Digital PlatforM to sUpport paTients with Heart Failure' (AZIMUTH) study is a multicentre prospective outpatient trial asses
